In this double-blind study we compared the influence of two oral contraceptives, a 23-day
regimen with 20 μg ethinyl estradiol and 75 μg gestodene (23-day 20/75) and a 21-day …

The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …

This open, prospective, noncomparative study evaluated clinical and metabolic aspects of
the use of a contraceptive combination of ethinyl estradiol (30 μg) and gestodene (75 μg) …

A well-known triphasic oral contraceptive (OC) containing ethinyl estradiol (EE) plus
levonorgestrel (LNG) was compared with a triphasic containing the same dose of EE in …

In this open label, randomized study we compared the influence of a dose-reduced oral
contraceptive containing 20 μg ethinyl estradiol (EE) and 100 μg levonorgestrel (20 EE) with …

The changes in haemostasis during oral contraception are related to the ethinylestradiol
dose present in the formulation taken by the patient. An open, randomized longitudinal study …

The effect of a triphasic oral contraceptive containing ethinyl estradiol and gestodene
(EE/GSD) on various lipid and lipoprotein parameters was compared with that of a …

The clinical and metabolic effects of a short-term treatment with a combination contraceptive
pill containing 30 mcg ethinylestradiol and 75 mcg gestodene were evaluated in a group of …

We examined the influence on carbohydrate and lipoprotein metabolism of oral
contraceptives (OCs) containing two new third-generation progestogens, desogestrel and …

An open comparison at a single center was performed in volunteers (n= 58) randomly
allocated to two treatment groups, one receiving tablets containing 20 μg ethinylestradiol …